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TCTAP A-137
Impact of Diabetes Mellitus as well as History of Cerebral Infarction
on Clopidogrel Response Variability in Patients with Chronic Coronary
Artery Disease
Keishi Ichikawa1
1Iwakuni Clinical Center, Japan
BACKGROUND Dual antiplatelet therapy with aspirin and clopidogrel
is standard for prevention of coronary stent thrombosis. Response
variability of these medications is well-known; however, factors
associated with this variability have not been fully elucidated.
METHODS 46 patients scheduled for elective PCI were enrolled (73 
8 years, 38 males). Platelet aggregability was assessed by light trans-
mission aggregometry after stimulation with ADP and collagen. All
patients were received aspirin (100 mg) and clopidogrel (75 mg) for at
least 7 days before the blood test. Platelet aggregability grade was
calculated (1 to 9), and patients with grade 7 to 9 were deﬁned as non-
responder.
RESULTS 10 patients (22%) were determined as non-responder to clo-
pidogrel, whereas all patients were responders to aspirin. Non-re-
sponders to clopidogrel had higher ratio of female (40% vs. 11%,
p¼0.033), higher prevalence of hypertension (90% vs. 56%, p¼0.047),
diabetes mellitus (70% vs. 31%, p¼0.024) and history of cerebral
infarction (30% vs. 3%, p¼0.006). By logistic regression analysis, female
gender, prevalence of diabetesmellitus andhistory of cerebral infarction
were independent determinants of non-responder to clopidogrel.
CONCLUSION Female gender, prevalence of diabetes mellitus and
cerebral infarction was risk for clopidogrel resistance. Evaluation of
platelet aggregation after administration of antiplatelet therapy
should be done, especially in patients with diabetes mellitus and
history of cerebral infarction.BASIC SCIENCE, ANIMAL MODELS AND PRECLINICAL
STUDIES (TCTAP A-138 TO TCTAP A-142)
TCTAP A-138
Insulin Enhances Dendritic Cells Scavenger Receptor-Mediated Endocytic
Uptake of oxLDL
Hao Lu,1 Dong Huang,1 Jianying Ma,1 Juying Qian,1 Junbo Ge1
1Zhongshan Hospital, Fudan University, Shanghai, China
BACKGROUND The prevalence of atherosclerotic cardiovascular dis-
ease is higher in patients with type 2 diabetes, a disorder characterized
by hyperinsulinemia and insulin resistance. The role of hyper-
insulinemia as an independent participant in the atherogenic process
has been controversial. Therefore, we examined whether insulin could
regulate the expression of scavenger receptors responsible for oxidized
low-density lipoprotein (oxLDL) uptake in DCs, a critical step in
atherogenesis. In addition, we investigated the impact of insulin on DC
maturation regarding changes in phenotype and cytokine secretion.
METHODS Immature DCs were cultured with different concentrations
of insulin (1nmol/L, 10nmol/L, 100nmol/L) in the absence or presence
of LY294002 or wartmannin for 24 hours. The expression of the
scavenger receptors SR-A and CD36 was determined by real-time PCR
and western blot analysis. Furthermore, DCs were incubated with
DiI-labelled oxLDL. The DiI-oxLDL-incorporated fraction was inves-
tigated by ﬂow cytometry analysis. Finally, ﬂow cytometry analysis
was used to investigate immunophenotypic protein expression (CD83
and CD11a). DC-differentiation was evaluated using the expression of
BDCTCTAP A-1/-2 by ﬂow cytometer analysis. Supernatant cytokine
measurements were used for immune function assays.
RESULTS The incubation of DCs with insulin enhanced, in a dose-
dependent manner, the gene and protein expression of SR-A and
CD36. This effect was partially abolished by wartmannin, a phospha-
tidylinositol-3-OH kinase (PI3 kinase) inhibitor. But LY294002 did not
inhibit the effect of insulin on scavenger receptors’ expression. High
concentration of insulin increased the oxLDL-uptake capacity of DCs.
Blockage of the scavenger receptors SR-A and CD36 signiﬁcantly
reduced oxLDL uptake. Furthermore, high concentration of insulin
induced DC-maturation and triggered differentiation of DCs in
myeloid and plasmacytoid DCs. Finally, high concentration of insulin
decreased IL-10 secretion and increased IL-6release.CONCLUSION This study suggests that hyperinsulinemia could pro-
mote DC activation and oxLDL uptake and thus may contribute to
atherosclerosis in patients with type 2 diabetes.
TCTAP A-139
Tongxinluo Treatment Protects Infarcted Rat Hearts by Increasing
Autophagy and Decreasing Apoptosis via AMPK/mTOR Pathway
Qing Li,1 Yue-Jin Yang1
1Fuwai Hospital, CAMS&PUMC, China
BACKGROUND Our previous studies have demonstrated the pro-
survival role of Tongxinluo (TXL) on cardiomyocytes after acute
myocardial infarction (AMI), but the underlying mechanisms are still
unknown. The present study was to investigate whether TXL could
have an effect on autophagy of cardiomyocytes via the AMPK/mTOR
pathway, and to investigate the interaction of autophagy and
apoptosis.
METHODS In vitro, H9C2 cardiomyocytes were exposed to TXL (800
m g/ml) and Compound C (10 m mol/L) treatments and subjected to
hypoxia each for 3 hours, were then moved to normal conditions for 1
hours of reoxygenation. After the treatment, cells were harvested and
analyzed at 1h, 2h, 4h, 12h, 24h. In vivo, Male Sprague-Dawley rats
(n¼100) were randomly assigned to sham, control, TXL (4 mg/kg/d),
TXL þ Compound C (intraperitoneal injection at 20 mg/kg per week)
groups. TXL and Compound C were given from 1 week before rat
coronary artery ligation model were established. Transthoracic echo-
cardiography and pathological studies were performed to investigate
the cardiac function and the extent of ﬁbrosis, infarct size. The
expression of apoptotic proteins, autophagy proteins and AMPK
pathway proteins were detected by western blotting analysis.
RESULTS In vitro, TXL enhanced autophagy and decreased apoptosis
in a dose-dependent manner. Inhibition of autophagy by knocking
down of Atg7 attenuated cell death. TXL upregulated AMPK and
mTOR phosphorylation. However, Compound C abrogated AMPK
phosphorylation and decreased autophagy and increased apoptosis.
In vivo, compared with the control group, the TXL group increased
ejection fraction by 10% four weeks after the operation and substan-
tially decreased the ﬁbrosis, infarcted area (p<0.05).TXL treatment
increased the AMPK activity and the expression of autophagy protein
LC3 in the reﬂow and no-reﬂow myocardium (p<0.05) and inhibited
the elevation of apoptotic protein as bax, caspase-3. Addition of the
AMPK inhibitor Compound C counteracted these beneﬁcial effects.
CONCLUSION AMP-mediated cardioprotection of TXL against no-
reﬂow and reperfusion injury relates to the inhibition of apoptosis and
promotion of autophagy in myocardium in rats.
TCTAP A-140
Evaluation of Radial Strength and Stiffness in Coronary Stents
Takashi Sasou1
1Mie University Hospital, Japan
BACKGROUND Acute stent recoil has been radial strength hand
stiffness are important determinants of the mechanical performance
of coronary stents. In this study, we quantitatively evaluated the
radial strength hand stiffness of four types of stent.
METHODS The test involved compression of the expanded stent at a
speciﬁed pressure in the radial direction with a uniform 25% load.
Radial strength and rigidity were calculated from the displacement
curves for the radial strength of each stent as follows.
RESULTS Resolute Integrity (a), 0.280  0.001; Endeavor Sprint (B),
0.263  0.001; Promus Element (C), 0.283  0.001; and Nobori (D),
0.245  0.001 N/mm. Radial stiffness was also calculated: a, 0.567
0.001; B, 0.517  0.001; C, 0.541  0.001; and D, 0.494  0.001.
CONCLUSION The radial strength and stiffness of different stents was
evaluated quantitatively under the same conditions. It is possible that
selection of stents based on these parameters might contribute to risk
reduction in both in animal experiments and clinical evaluation.
